Article
Treatment of a metabolic liver disease by <i>in vivo</i> prime editing in mice
2021-08-17
Abstract excerpt
Prime editing is a highly versatile CRISPR-based genome editing technology with the potential to correct the vast majority of pathogenic mutations (1) . However, correction of a disease phenotype in vivo in somatic tissues has not been demonstrated thus far. Here, we establish proof-of-concept for in vivo prime editing and repair the metabolic liver disease phenylketonuria (PKU) in mice. We first developed a si...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 1ce589f6-448b-5e64-bedf-ab9dd42d4d5d
- DOI
- 10.1101/2021.08.17.456632
